Surgical treatment for gum tissue issues after removing localized growths

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial focuses on addressing non-inflammatory recessions and mucogingival defects that occur after the surgical removal of localized gingival enlargements. The study employs techniques such as the subperiosteal envelope technique combined with connective tissue grafts to enhance keratinized tissue and promote root coverage. By evaluating the effectiveness of these surgical interventions, the trial aims to reduce postoperative complications like recurrence and gingival recessions. The goal is to improve oral hygiene maintenance and overall periodontal health for affected patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* patients older than 18 years
* systematically healthy patients
* localized gingival enlargement is present that involves maximum 3 teeth

Exclusion Criteria:

* pregnant women
* medication intake that can potentially affect the oral mucosa and its healing
* heavy smokers (\>=15)

Where it's running

• Semmelweis University, Faculty of Dentistry
  Budapest, Hungary Recruiting

Study contacts

• Principal investigator: Bálint Molnár — Semmelweis University
• Study coordinator: Bálint Molnár
• Email: molbal81@gmail.com
• Phone: +36 1 318 5222

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Surgical approach for treating advanced gum disease with grafting

  This study is testing a new surgical technique for people with advanced gum disease to see if it helps their gums heal better and improves their overall dental health.

  Recruiting Universidad de Murcia · Murcia · NCT03997578

• Non-Thermal Plasma Used During Surgery to Help Prevent Recurrent Chronic Subdural Hematoma

  A randomized trial tests whether applying non-thermal plasma during standard surgery to drain a chronic subdural hematoma can reduce recurrence within 6 months.

  Recruiting National Institute of Nuclear Research - Mexico · Ocoyoacac, State of Mexico · NCT07656818

• Intratumoral DNX-2401 for High-Grade Pediatric Brain Tumors

  This study tests whether a single injection of DNX-2401 into a pediatric brain tumor can help shrink the tumor and extend survival in kids and young adults with recurrent or refractory high-grade brain tumors.

  Recruiting Phase 2 Clinica Universidad de Navarra, Universidad de Navarra · Utrecht and 1 other locations · NCT07424092

• xDRIVE personalized tumor testing for Florida cancer patients

  This program will try a functional precision medicine and AI platform (xDRIVE) to help guide next treatment options for Florida patients with recurrent or refractory cancer, including children and people from underserved communities.

  Recruiting First Ascent Biomedical Inc. · Miami, Florida and 1 other locations · NCT07167381

• How exercise relates to health and cancer outcomes in adult survivors

  This project will see if exercising after treatment is linked to cancer outcomes and other health events in adults who have finished primary cancer therapy.

  Recruiting Memorial Sloan Kettering Cancer Center · Los Angeles, California and 2 other locations · NCT07030686

• Real-world look at SKB264 in HER2-negative breast cancer that has come back or spread

  This real-world study tests sacituzumab tirumotecan (SKB264) alone or with others in adults with recurrent or metastatic HER2-negative breast cancer.

  Recruiting at 12 sites Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Hefei, Anhui and 18 other locations · NCT06993506

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.